| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 16 | 2023 | 1618 | 1.200 |
Why?
|
| Poloxamer | 6 | 2012 | 16 | 1.060 |
Why?
|
| Nephrectomy | 5 | 2012 | 91 | 0.920 |
Why?
|
| Radiology, Interventional | 2 | 2023 | 32 | 0.890 |
Why?
|
| Robotics | 2 | 2023 | 87 | 0.840 |
Why?
|
| Radiology Department, Hospital | 2 | 2020 | 24 | 0.810 |
Why?
|
| Biliary Tract Surgical Procedures | 2 | 2018 | 12 | 0.760 |
Why?
|
| Lung Neoplasms | 7 | 2021 | 670 | 0.750 |
Why?
|
| Hepatectomy | 2 | 2018 | 63 | 0.680 |
Why?
|
| Penile Induration | 1 | 2020 | 2 | 0.670 |
Why?
|
| Embolization, Therapeutic | 7 | 2013 | 318 | 0.660 |
Why?
|
| Iohexol | 4 | 2012 | 18 | 0.660 |
Why?
|
| Hemostasis, Surgical | 4 | 2012 | 21 | 0.640 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2018 | 26 | 0.600 |
Why?
|
| Robotic Surgical Procedures | 1 | 2021 | 161 | 0.570 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2018 | 178 | 0.560 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2021 | 2164 | 0.560 |
Why?
|
| Liver Neoplasms | 2 | 2018 | 297 | 0.530 |
Why?
|
| Biliary Tract Diseases | 2 | 2018 | 22 | 0.450 |
Why?
|
| Thoracic Surgery, Video-Assisted | 2 | 2015 | 61 | 0.450 |
Why?
|
| Pneumothorax, Artificial | 1 | 2014 | 1 | 0.440 |
Why?
|
| Fiducial Markers | 1 | 2014 | 4 | 0.440 |
Why?
|
| Contrast Media | 6 | 2011 | 424 | 0.440 |
Why?
|
| Chest Tubes | 1 | 2014 | 17 | 0.440 |
Why?
|
| Coronary Sinus | 1 | 2013 | 5 | 0.430 |
Why?
|
| Vascular Fistula | 1 | 2013 | 8 | 0.430 |
Why?
|
| Renal Artery | 3 | 2011 | 37 | 0.430 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2014 | 58 | 0.420 |
Why?
|
| Pneumonectomy | 1 | 2014 | 109 | 0.410 |
Why?
|
| Heart Defects, Congenital | 1 | 2013 | 102 | 0.390 |
Why?
|
| Needles | 2 | 2023 | 67 | 0.370 |
Why?
|
| Surgical Instruments | 1 | 2011 | 43 | 0.370 |
Why?
|
| Postoperative Complications | 1 | 2018 | 1302 | 0.360 |
Why?
|
| Blood Loss, Surgical | 4 | 2012 | 65 | 0.350 |
Why?
|
| Cholangiography | 2 | 2018 | 42 | 0.340 |
Why?
|
| Hemostatics | 1 | 2010 | 26 | 0.320 |
Why?
|
| External Fixators | 2 | 2021 | 6 | 0.320 |
Why?
|
| Fracture Fixation | 2 | 2021 | 18 | 0.310 |
Why?
|
| Kidney | 1 | 2011 | 447 | 0.310 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2010 | 129 | 0.310 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2008 | 10 | 0.300 |
Why?
|
| Varicocele | 1 | 2008 | 5 | 0.300 |
Why?
|
| Humans | 36 | 2023 | 63297 | 0.290 |
Why?
|
| Sperm Motility | 1 | 2008 | 49 | 0.290 |
Why?
|
| Infertility, Male | 1 | 2008 | 57 | 0.290 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 2 | 2018 | 47 | 0.270 |
Why?
|
| Male | 26 | 2021 | 29821 | 0.260 |
Why?
|
| Middle Aged | 20 | 2020 | 17553 | 0.260 |
Why?
|
| Swine | 6 | 2012 | 374 | 0.240 |
Why?
|
| Early Detection of Cancer | 4 | 2021 | 319 | 0.240 |
Why?
|
| Phantoms, Imaging | 3 | 2021 | 214 | 0.230 |
Why?
|
| Myocardial Infarction | 2 | 2003 | 914 | 0.230 |
Why?
|
| Gadolinium DTPA | 2 | 2002 | 87 | 0.220 |
Why?
|
| Mesenteric Veins | 2 | 2013 | 11 | 0.210 |
Why?
|
| Manganese Compounds | 1 | 2003 | 8 | 0.200 |
Why?
|
| Arteriovenous Fistula | 2 | 2013 | 41 | 0.200 |
Why?
|
| Oxygen | 4 | 2012 | 315 | 0.200 |
Why?
|
| Organometallic Compounds | 1 | 2003 | 65 | 0.190 |
Why?
|
| Feasibility Studies | 6 | 2018 | 568 | 0.190 |
Why?
|
| Biopsy | 1 | 2023 | 444 | 0.190 |
Why?
|
| Carbon Dioxide | 3 | 2010 | 86 | 0.190 |
Why?
|
| Adult | 13 | 2018 | 16781 | 0.180 |
Why?
|
| Workflow | 1 | 2020 | 69 | 0.170 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 1083 | 0.170 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 60 | 0.170 |
Why?
|
| Retrospective Studies | 6 | 2020 | 6630 | 0.160 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 96 | 0.160 |
Why?
|
| Penis | 1 | 2020 | 32 | 0.160 |
Why?
|
| Sensitivity and Specificity | 8 | 2014 | 1146 | 0.150 |
Why?
|
| Jejunostomy | 1 | 2018 | 7 | 0.150 |
Why?
|
| Phlebography | 4 | 2013 | 44 | 0.150 |
Why?
|
| Aged | 15 | 2018 | 14394 | 0.150 |
Why?
|
| Pilot Projects | 2 | 2020 | 1006 | 0.140 |
Why?
|
| Computer Simulation | 1 | 2020 | 477 | 0.140 |
Why?
|
| Fracture Healing | 1 | 2017 | 26 | 0.140 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2011 | 185 | 0.140 |
Why?
|
| Female | 21 | 2018 | 32791 | 0.140 |
Why?
|
| Diagnosis-Related Groups | 1 | 2017 | 87 | 0.130 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 108 | 0.130 |
Why?
|
| Stents | 2 | 2011 | 491 | 0.130 |
Why?
|
| Endovascular Procedures | 2 | 2013 | 648 | 0.130 |
Why?
|
| Fractures, Bone | 1 | 2017 | 143 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2021 | 3285 | 0.120 |
Why?
|
| Treatment Outcome | 5 | 2018 | 5656 | 0.120 |
Why?
|
| Ureteroscopes | 1 | 2015 | 4 | 0.120 |
Why?
|
| Choledocholithiasis | 1 | 2015 | 5 | 0.120 |
Why?
|
| Lithotripsy, Laser | 1 | 2015 | 5 | 0.120 |
Why?
|
| Patient Compliance | 1 | 2017 | 360 | 0.120 |
Why?
|
| Angiography, Digital Subtraction | 5 | 2013 | 134 | 0.120 |
Why?
|
| Mass Screening | 3 | 2017 | 690 | 0.110 |
Why?
|
| Reproducibility of Results | 4 | 2014 | 1649 | 0.110 |
Why?
|
| Inpatients | 1 | 2017 | 303 | 0.110 |
Why?
|
| Liver | 3 | 2011 | 851 | 0.110 |
Why?
|
| Colitis, Ischemic | 1 | 2013 | 1 | 0.110 |
Why?
|
| Mesenteric Artery, Inferior | 1 | 2013 | 4 | 0.110 |
Why?
|
| Hypercapnia | 2 | 2010 | 9 | 0.110 |
Why?
|
| Hyperoxia | 2 | 2010 | 17 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2015 | 182 | 0.110 |
Why?
|
| Diagnostic Errors | 1 | 2014 | 98 | 0.100 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2013 | 110 | 0.100 |
Why?
|
| Heart Atria | 1 | 2013 | 138 | 0.100 |
Why?
|
| Radiology | 1 | 2017 | 252 | 0.100 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2012 | 14 | 0.100 |
Why?
|
| Statistics, Nonparametric | 3 | 2008 | 214 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 342 | 0.100 |
Why?
|
| Smoking | 2 | 2014 | 865 | 0.100 |
Why?
|
| Oximetry | 1 | 2012 | 48 | 0.100 |
Why?
|
| Renal Circulation | 1 | 2012 | 14 | 0.100 |
Why?
|
| Oxides | 2 | 2002 | 37 | 0.100 |
Why?
|
| Liver Circulation | 1 | 2011 | 11 | 0.090 |
Why?
|
| Molecular Imaging | 1 | 2012 | 48 | 0.090 |
Why?
|
| Hepatic Artery | 1 | 2011 | 20 | 0.090 |
Why?
|
| Portal Vein | 1 | 2011 | 38 | 0.090 |
Why?
|
| Animals | 8 | 2012 | 20631 | 0.090 |
Why?
|
| Glioblastoma | 2 | 2010 | 158 | 0.090 |
Why?
|
| Colectomy | 1 | 2012 | 108 | 0.090 |
Why?
|
| Random Allocation | 1 | 2011 | 199 | 0.090 |
Why?
|
| Iron | 2 | 2002 | 148 | 0.090 |
Why?
|
| Patient Selection | 1 | 2013 | 488 | 0.080 |
Why?
|
| Brain Neoplasms | 2 | 2010 | 308 | 0.080 |
Why?
|
| Respiration | 1 | 2010 | 89 | 0.080 |
Why?
|
| Cerebral Angiography | 1 | 2011 | 290 | 0.080 |
Why?
|
| Brain Mapping | 1 | 2010 | 232 | 0.080 |
Why?
|
| Brain | 4 | 2010 | 1555 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 2009 | 81 | 0.080 |
Why?
|
| Temperature | 1 | 2010 | 307 | 0.070 |
Why?
|
| Sperm Count | 1 | 2008 | 15 | 0.070 |
Why?
|
| Sclerosing Solutions | 1 | 2008 | 6 | 0.070 |
Why?
|
| Laparoscopy | 2 | 2011 | 491 | 0.070 |
Why?
|
| Propranolol | 1 | 2008 | 20 | 0.070 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2008 | 19 | 0.070 |
Why?
|
| Tetrazoles | 1 | 2008 | 22 | 0.070 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 25 | 0.070 |
Why?
|
| Biphenyl Compounds | 1 | 2008 | 32 | 0.070 |
Why?
|
| Hypertension, Portal | 1 | 2008 | 16 | 0.070 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2009 | 111 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 563 | 0.070 |
Why?
|
| Radiography, Interventional | 1 | 2008 | 74 | 0.070 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2008 | 150 | 0.070 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 168 | 0.070 |
Why?
|
| Intracranial Aneurysm | 1 | 2011 | 366 | 0.070 |
Why?
|
| Antihypertensive Agents | 1 | 2008 | 166 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2008 | 171 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2003 | 153 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2013 | 837 | 0.060 |
Why?
|
| Logistic Models | 1 | 2008 | 1275 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2005 | 246 | 0.050 |
Why?
|
| Hippocampus | 2 | 2003 | 270 | 0.050 |
Why?
|
| Radiology Information Systems | 2 | 2014 | 34 | 0.050 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2003 | 3 | 0.050 |
Why?
|
| Time Factors | 4 | 2012 | 3761 | 0.050 |
Why?
|
| Intracranial Embolism | 1 | 2003 | 39 | 0.050 |
Why?
|
| Thalamus | 1 | 2003 | 72 | 0.050 |
Why?
|
| Aspartic Acid | 1 | 2002 | 28 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2021 | 2077 | 0.050 |
Why?
|
| Abdomen | 1 | 2002 | 91 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 5446 | 0.050 |
Why?
|
| Neoplasms | 1 | 2012 | 1359 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2003 | 608 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 619 | 0.040 |
Why?
|
| Tissue Survival | 1 | 2001 | 5 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2002 | 294 | 0.040 |
Why?
|
| Magnets | 1 | 2021 | 3 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2003 | 190 | 0.040 |
Why?
|
| Pregnancy | 1 | 2008 | 2330 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2010 | 659 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2003 | 281 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2012 | 178 | 0.040 |
Why?
|
| Cadaver | 1 | 2021 | 128 | 0.040 |
Why?
|
| Aortic Valve Stenosis | 1 | 2003 | 188 | 0.040 |
Why?
|
| Radiologists | 1 | 2021 | 88 | 0.040 |
Why?
|
| Rats | 1 | 2003 | 1977 | 0.040 |
Why?
|
| Surgical Stomas | 1 | 2018 | 9 | 0.040 |
Why?
|
| Risk Factors | 3 | 2017 | 5343 | 0.040 |
Why?
|
| Punctures | 1 | 2018 | 64 | 0.040 |
Why?
|
| Catheterization | 1 | 2018 | 111 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2018 | 114 | 0.040 |
Why?
|
| United States | 3 | 2017 | 7828 | 0.030 |
Why?
|
| Adolescent | 1 | 2008 | 6238 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2017 | 109 | 0.030 |
Why?
|
| Neuroradiography | 1 | 2017 | 11 | 0.030 |
Why?
|
| Artifacts | 2 | 2011 | 125 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2017 | 123 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 349 | 0.030 |
Why?
|
| Mediastinoscopy | 1 | 2015 | 8 | 0.030 |
Why?
|
| Lung | 1 | 2021 | 953 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 317 | 0.030 |
Why?
|
| Hamartoma | 1 | 2015 | 12 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2003 | 2180 | 0.030 |
Why?
|
| Granuloma | 1 | 2015 | 41 | 0.030 |
Why?
|
| Thoracotomy | 1 | 2015 | 46 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2002 | 721 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 372 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 869 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2014 | 253 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 259 | 0.030 |
Why?
|
| Length of Stay | 1 | 2017 | 811 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 1749 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2013 | 93 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2012 | 60 | 0.020 |
Why?
|
| Ferrosoferric Oxide | 2 | 2002 | 18 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 255 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 337 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2013 | 132 | 0.020 |
Why?
|
| Dextrans | 2 | 2002 | 46 | 0.020 |
Why?
|
| Magnetite Nanoparticles | 2 | 2002 | 28 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2012 | 151 | 0.020 |
Why?
|
| Organ Sparing Treatments | 1 | 2011 | 16 | 0.020 |
Why?
|
| Cattle | 1 | 2011 | 308 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2012 | 192 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1121 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 236 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2012 | 581 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1375 | 0.020 |
Why?
|
| Echo-Planar Imaging | 1 | 2010 | 33 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2010 | 54 | 0.020 |
Why?
|
| Meningioma | 1 | 2010 | 60 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 474 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 735 | 0.020 |
Why?
|
| Chest Pain | 1 | 2009 | 84 | 0.020 |
Why?
|
| Massachusetts | 1 | 2014 | 2077 | 0.020 |
Why?
|
| Portal Pressure | 1 | 2008 | 1 | 0.020 |
Why?
|
| Natriuresis | 1 | 2008 | 7 | 0.020 |
Why?
|
| Renin | 1 | 2008 | 10 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2008 | 40 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2013 | 690 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 264 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2008 | 738 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 860 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2009 | 554 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2005 | 201 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 2003 | 25 | 0.010 |
Why?
|
| Putamen | 1 | 2003 | 21 | 0.010 |
Why?
|
| Pressure | 1 | 2003 | 79 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2005 | 288 | 0.010 |
Why?
|
| Kidney Cortex | 1 | 2002 | 10 | 0.010 |
Why?
|
| Creatine | 1 | 2002 | 24 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 2002 | 25 | 0.010 |
Why?
|
| Diffusion | 1 | 2002 | 82 | 0.010 |
Why?
|
| Choline | 1 | 2002 | 23 | 0.010 |
Why?
|
| Rabbits | 1 | 2002 | 332 | 0.010 |
Why?
|
| Observer Variation | 1 | 2002 | 213 | 0.010 |
Why?
|
| ROC Curve | 1 | 2002 | 281 | 0.010 |
Why?
|
| Spleen | 1 | 2002 | 483 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 4682 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 972 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2003 | 2571 | 0.010 |
Why?
|